Reversion-Inducing Cysteine-Rich Protein With Kazal Motifs (RECK) Antibody

Product Graph
637€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Reversion-Inducing Cysteine-Rich Protein With Kazal Motifs (RECK) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx115171
tested applications
ELISA, WB

Description

Reversion-Inducing-Cysteine-Rich Protein With Kazal Motifs Antibody is a Rabbit Polyclonal antibody against Reversion-Inducing-Cysteine-Rich Protein With Kazal Motifs.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Target: Reversion-Inducing Cysteine-Rich Protein With Kazal Motifs (RECK)
Immunogen: Human RECK.
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Antigen Affinity Chromatography.
Size 1
100 µl
Form
Liquid
Tested Applications
ELISA, WB
Buffer
PBS, pH 7.3, containing 0.02% Sodium Azide and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
O95980
Gene ID
8434
OMIM
605227
Background
Antibody anti-RECK
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Descripción

Related Products

EH2262

Human RECK (Reversion-inducing cysteine-rich protein with Kazal motifs) ELISA Kit

Ver Producto
FNab07224

RECK antibody

Negatively regulates matrix metalloproteinase-9(MMP-9) by suppressing MMP-9 secretion and by direct inhibition of its enzymatic activity. RECK down-regulation by oncogenic signals may facilitate tumor invasion and metastasis. Appears to also regulate MMP-2 and MT1-MMP, which are involved in cancer progression.

Ver Producto
FNab10074

RECK antibody

Negatively regulates matrix metalloproteinase-9(MMP-9) by suppressing MMP-9 secretion and by direct inhibition of its enzymatic activity. RECK down-regulation by oncogenic signals may facilitate tumor invasion and metastasis. Appears to also regulate MMP-2 and MT1-MMP, which are involved in cancer progression.

Ver Producto